Companies and Markets
Call us on +44 (0) 203 086 8600
Market Research A to Z | Company Profiles A to Z | RegisterRegister | Contact UsContact Us | Shopping Basket Shopping Basket
+44 (0) 203 086 8600 Call us on

Santaris Pharma A/S - Product Pipeline Review - 2012

918.42

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Site License

Site License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£918.42

Change Currency

GBP EURO USD
GBP EURO USD

Market

Healthcare and Medical

Report Type

Company Profile

Country

Global

Published

31 August 2012

Number of Pages

69

Report Delivery

Email

Delivery Lead Time

1-3 hours, 24 hour max

Publisher

Global Markets Direct

File Format

PDF

Santaris Pharma A/S - Product Pipeline Review - 2012 - This pharmaceuticals report, "Santaris Pharma A/S - Product Pipeline Review - 2012" provides data on the Santaris Pharma A/S's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from our proprietary databases, Santaris Pharma A/S's corporate website, SEC filings, investor presentations and featured press releases, both from Santaris Pharma A/S and industry-specific third party sources, put together by This team.

Scope

- Santaris Pharma A/S - Brief Santaris Pharma A/S overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Santaris Pharma A/S human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Santaris Pharma A/S with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Santaris Pharma A/S's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Santaris Pharma A/S's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Santaris Pharma A/S in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Santaris Pharma A/S's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Santaris Pharma A/S.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Santaris Pharma A/S and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Santaris Pharma A/S; Santaris Pharma A/S - Key Therapeutics; Santaris Pharma A/S - Pipeline Overview and Promising Molecules; Santaris Pharma A/S - News; Santaris Pharma A/S - Latest Updates; Santaris Pharma A/S - Pipeline; Santaris Pharma A/S - Discontinued/Dormant Projects

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Site License

Site License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£918.42

Change Currency

GBP EURO USD

Change Currency

GBP
USD

Visitor Comments

All posts are pre-moderated and must obey the house rules.

Change Currency

GBP
USD

Use our research skills: Get free support

Free Research Support: Let us do the work for you and find information from public and private sources of information. Contact us now and we can save you time and money.......Free Research Support

eBrandPromote: Get your brands ranked highly online

eBrandPromote: Let us promote your brand online through article writing, press release distribution, social media and search engine marketing services. Click here to download our eBrandPromote brochure.

Accessibility
Close

Contrast settings

Text size settings